C-reactive protein as an early marker of immune-related adverse events
ConclusionCRP elevation can predict the onset of irAEs in patients treated with ICIs in the absence of infectious disease.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Autoimmune Disease | Cancer | Cancer & Oncology | Infectious Diseases | Melanoma | Skin Cancer | Statistics | Study